Genetics, Management, and Clinical Outcomes in Familial Exudative Vitreoretinopathy (FEVR): A Multicentre Retrospective Cohort
Klinische Monatsblätter für Augenheilkunde · 12.11.2026
DOI: 10.1055/a-2962-8394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, online erschienen am 12.11.2026. Verfasst von Tomasz Szeligowski und 11 weiteren Autor:innen. Beteiligte Einrichtung: Oxford University Hospitals NHS Foundation Trust, Oxford Eye Hospital, England, United Kingdom of Great Britain and Northern Ireland, Oxford. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Oxford Biomedical Research Centre, Manchester Biomedical Research Centre, Wellcome Trust.
Abstract (Originalsprache)
Familial exudative vitreoretinopathy (FEVR) is a group of inherited retinal diseases characterised by abnormal retinal angiogenesis and peripheral non-perfusion. While over 10 genes have been implicated in FEVR, genotype–phenotype correlations and their clinical significance are incompletely understood. Here we describe a retrospective cohort of FEVR patients and assess the impact of defined genetic variants on protein structure, disease severity, inter-ocular variability, as well as treatment choices and visual outcomes. The study involved a retrospective cohort of 51 patients with FEVR across three UK paediatric retina centres. All data were obtained from routine clinical records. Standard FEVR staging system was used throughout. Identified genetic variants were checked against genomic databases (ClinVar, GnomAD, UniProt), and their structural impact was examined using in silico algorithms (MutationTaster and PolyPhen2) to determine the likelihood of pathogenicity. In all, 51 patients were included, with variants identified in FZD4 (n = 16), LRP5 (n = 13), TSPAN12 (n = 11), KIF11 (n = 6), NDP (n = 4), and CTNNB1 (n = 1). In silico analysis identified 11 variants not previously reported in FEVR, 7 of which were classified as likely pathogenic. NDP variants were associated with the most severe and asymmetrical disease. Management included conservative monitoring (45 eyes), retinal laser photocoagulation (39 eyes), and surgical interventions (12 eyes), with the majority of patients achieving stable or improved visual acuity in all treatment groups. This study demonstrates significant diversity among FEVR patients with regard to genetic variants, clinical presentation, and visual outcomes. Understanding genotype–phenotype correlations in FEVR may be crucial for developing novel treatment strategies.
Autor:innen und Institutionen
- Oxford University Hospitals NHS Foundation Trust, Oxford Eye Hospital, England, United Kingdom of Great Britain and Northern Ireland, Oxford.
- Great Ormond Street Hospital for Children, Ophthalmology, England, United Kingdom of Great Britain and Northern Ireland, London.
- Manchester University NHS Foundation Trust, Manchester Royal Eye Hospital, England, United Kingdom of Great Britain and Northern Ireland, Manchester.
- University of Oxford Nuffield, Department of Clinical Neurosciences, Nuffield Laboratory of Ophthalmology, England, United Kingdom of Great Britain and Northern Ireland, Oxford.
- Manchester University NHS Foundation Trust, Manchester Centre for Genomic Medicine, England, United Kingdom of Great Britain and Northern Ireland, Manchester.
- The University of Manchester School of Biological Sciences, Division of Evolution, Infection, and Genomics, England, United Kingdom of Great Britain and Northern Ireland, Manchester.
ORCID-Profile: Kanmin Xue
Förderung
- NIHR Oxford Biomedical Research Centre
- Manchester Biomedical Research Centre
- Wellcome Trust
Zitieren
APA
Szeligowski, T., Ie, A., Kiraly, P., Hu, M., Ivanova, T., Jalil, A., Sergouniotis, P., Black, G., Wong, S. C., Patel, C. K., Henderson, R., & Xue, K. (2026). Genetics, Management, and Clinical Outcomes in Familial Exudative Vitreoretinopathy (FEVR): A Multicentre Retrospective Cohort. Klinische Monatsblätter für Augenheilkunde. https://doi.org/10.1055/a-2962-8394
Vancouver
Szeligowski T, Ie A, Kiraly P, Hu M, Ivanova T, Jalil A, et al. Genetics, Management, and Clinical Outcomes in Familial Exudative Vitreoretinopathy (FEVR): A Multicentre Retrospective Cohort. Klinische Monatsblätter für Augenheilkunde. 2026. doi:10.1055/a-2962-8394
BibTeX
@article{Szeligowski2026,
author = {Szeligowski, Tomasz and Ie, Amanda and Kiraly, Peter and Hu, Monica and Ivanova, Tsveta and Jalil, Assad and Sergouniotis, Panagiotis and Black, Graeme and Wong, Sui Chien and Patel, Chetan K and Henderson, Robert and Xue, Kanmin},
title = {Genetics, Management, and Clinical Outcomes in Familial Exudative Vitreoretinopathy (FEVR): A Multicentre Retrospective Cohort},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2026},
doi = {10.1055/a-2962-8394}
}
EUVIMED